Additional support for EBF3 promoter hypermethylation in metastatic versus primary melanomas was obtained from EBF3 promoter methylation analysis in a second independent melanoma cohort, consisting of 450K methylation data for three normal melanocytes, four primary melanomas and 33 metastatic melanomas [14]. This evidence concerns the gene EBF3 and melanoma.